Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study
- First Online:
Glutamatergic dysfunction at N-methyl-d-aspartate (NMDA) receptors has been proposed as a neurochemical model for schizophrenia. A key feature of this disorder is impairments in cognitive function.
The present study sought to investigate the effects of ketamine, an NMDA antagonist, on the performance and neural correlates of verbal fluency, a task that engages executive function.
Ten healthy dextral male volunteers received intravenous placebo normal saline or ketamine (bolus of 0.23 mg/kg and infusion of 0.65 mg/kg), administered in a double-blind, randomized order, during two functional magnetic resonance imaging sessions. During scanning, subjects performed a verbal fluency task. Two levels of cognitive load were examined in the task, and overt responses were acquired in order to measure subject performance on-line.
Ketamine induced symptoms in the healthy individuals comparable to an acute psychotic state. Although ketamine did not significantly impair task performance relative to placebo, an interaction of task demand with ketamine was observed in the anterior cingulate, prefrontal, and striatal regions.
The behavioural and functional effects of ketamine during verbal fluency in healthy individuals were comparable to those evident in patients with schizophrenia. The findings support a role for glutamatergic dysfunction in the pathophysiology of schizophrenia.
KeywordsKetamine N-methyl-d-aspartate NMDA Schizophrenia Verbal fluency Executive function Functional magnetic resonance imaging fMRI
- Ammons R, Ammons C (1962) Quick Test Missoula, MT: psychological test specialistsGoogle Scholar
- Angrist BM, Peselow E, Rubenstein M et al (1982) Partial improvement in negative schizophrenic symptoms after amphetamine psychosis: preliminary observations. Biol Psychiatry 2:95–107Google Scholar
- Benton AL, Hamsher KD (1994) Multilingual aphasia examination. Oxford University Press, New YorkGoogle Scholar
- Bremner JD, Krystal JH, Putnam FW et al (1991) Measurement of dissociative states with the clinician administered dissociative states scale. J Trauma Stress 11:25–136Google Scholar
- Cotman CW, Monaghan DT (1987) Anatomical organization of excitatory amino acid receptors and their properties. Adv Exp Med Biol 203:237–252Google Scholar
- Coyle JT, Leski M, Morrison J (2001) Diverse role of l-glutamate acid in brain signal transduction. In: Neuropsychopharmacology: fifth generation of progress. Lippincott, New YorkGoogle Scholar
- Indefrey P, Levelt WJM (2000) The neural correlates of language production. In: Gazzaniga MS (ed) The new cognitive neurosciences, 2nd edn. MIT Press, Cambridge, MA, pp 845–865Google Scholar
- Lezak MD (1995) Neuropsychological assessment, 3rd edn. Oxford University Press, New York, pp 544–546Google Scholar
- Luby ED, Cohen BD, Rosenbaum F et al (1959) Study of a new schizophrenomimetic drug, Sernyl. Arch Neurol Psychiatry 81:363–369Google Scholar
- Rice CD, Done DJ, Manly T et al (2002) Schizophrenic patients with symptoms show more impairment than those without symptoms on an ecologically valid test of executive function. Schizophr Res 53:133Google Scholar
- Svensson TH, Mathe JM, Andersson JL et al (1995) Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism. J Clin Psychopharmacol 11–18SGoogle Scholar
- Talairach J, Tournoux P (1988) Co-planar stereotaxic atlas of the human brain. Thieme, New YorkGoogle Scholar
- Tso IF, Chan RCK, Chen EYH et al (2002) Longitudinal profiles of neurocognitive function in first-episode psychosis. Schizophr Res 53:121Google Scholar